𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Treatment of patients with advanced colorectal cancer with cisplatin, 5-fluorouracil, and leucovorin

✍ Scribed by Werner Scheithauer; H. Rosen; R. Schiessel; J. Schüller; M. Karall; F. Ernst; Ch. Sebesta; G. Kornek; E. Hentschel; A. Marczell; D. Depisch

Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
530 KB
Volume
67
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prognostic variables in patients with ad
Prognostic variables in patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy
✍ Fountzilas, George; Gossios, Konstantinos; Zisiadis, Alkis; Svarna, Eugenia; Ska 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 796 KB

Possible prognostic variables for tumor response, time to progression (XP), and survival in 141 patients with advanced colorectal cancer treated with fluorouracil and leucovorin-based chemotherapy were analyzed, None of the variables examined for their possible influence on tumor response attained s

Hypocalcemia associated with 5-fluoroura
Hypocalcemia associated with 5-fluorouracil and low dose leucovorin in patients with advanced colorectal or gastric carcinomas
✍ Yuichiro Kido; Takeshi Okamura; Morimasa Tomikawa; Manabu Yamamoto; Morio Shirai 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 367 KB 👁 2 views

## BACKGROUND. The biochemical modulation of 5-fluorouracil (5-FU) by leucovorin (Lv) has demonstrated significantly increased response rates in comparison with the use of 5-FU alone in patients with advanced colorectal carcinoma. However, the higher response rate of LV/5-FU may occur at the expen